Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Cancer company TetraLogic Pharmaceuticals (Malvern, Pa.) hired J. Kevin Buchi as president and CEO. He
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury